Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes
Year: 2026
Type: article
Abstract: Background: Jiebai-Qingfei San (JBQFS) is a seven-herb traditional Chinese veterinary formulation developed for respiratory disorders. However, its pharmacological effects against acute pulmonary inflammation and the associated molecular responses remain unclear. This study examined the protective activity of JBQFS in LPS-induced acute lung injury (ALI) and characterized the biological responses associated with treatment. Methods: The chemical profile of JBQFS was characterized by ultra-high-performance liquid chromatography coupled with high-resolution tandem mass spectrometry (UHPLC-HRMS/MS), and two representative marker compounds were quantified by high-performance liquid chromatography (HPLC). Lung transcriptomic analysis followed by qRT-PCR validation was performed to identify inflammation-related transcriptional responses. The effects of JBQFS were further examined in the murine alveolar macrophage cell line MH-S following LPS stimulation. Results: JBQFS pretreatment ameliorated LPS-induced alterations in respiratory parameters and attenuated histopathological injury, reduced inflammatory cytokine levels, and improved oxidative stress-related parameters. It also modulated macrophage-associated markers in lung tissue. Transcriptomic and qRT-PCR analyses showed that JBQFS administration was associated with changes in inflammation-related transcriptional responses, including genes related to TLR4/MyD88/NF-κB signaling. In MH-S cells, JBQFS reduced inflammatory mediator production and intracellular ROS and Ca2+ levels, preserved mitochondrial membrane potential, and modulated CD80, CD86, and CD206 expression. Conclusions: Pretreatment with JBQFS protected against LPS-induced ALI and was associated with reduced inflammation and oxidative stress, as well as modulation of macrophage-associated inflammatory phenotypes. These findings support further investigation of JBQFS for inflammatory respiratory disorders.
Source: Pharmaceuticals
DOI: 10.3390/ph19111835
Authors: Xiangwen Deng(Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft), Jin He(Data curation, Investigation, Methodology, Validation), Lin Yu(Investigation, Methodology, Validation), Yaming Yu(Investigation, Methodology), Kexin Fang(Data curation, Formal analysis, Visualization), Yang Yang(Supervision, Writing – review & editing), Deyun Wang(Conceptualization, Funding acquisition, Project administration, Supervision)
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Keywords: acute lung injury, lipopolysaccharide, traditional Chinese veterinary medicine, herbal medicine, oxidative stress, inflammation, alveolar macrophages, TLR4/MyD88/NF-κB signaling, macrophage polarization, CD80, CD86, CD206, reactive oxygen species, mitochondrial membrane potential, lung transcriptomics, respiratory inflammation
Open Access status: gold
Estimated APC paid: $3,499
Awards: G8425529861, G9001396592, G9001397118
OpenAlex ID: W7235939416
